Both mRNA-1020 and mRNA-1030 target hemagglutinin and neuraminidase antigens, two major influenza surface glycoproteins that are essential across the viral life cycle
If authorized by the USFDA, the Proof Lab Test System may be used to deliver accurate, actionable, lab-quality results for Covid-19 in as little as 18 minutes
The recombinant nanoparticle-based rabies G protein vaccine is prepared using virus-like particle technology.
Global event to kick off as the post-covid era begins in earnest, with theme "beyond the pandemic, into a next wave"
Macushield tablets assist with age-related macular degeneration, diabetic retinopathy and improves overall vision
R&D investment up 11.7% to 4.1 billion EUR in 2021 (20.0% of net sales)
Through this new set-up, the company intends to make available, affordable high-quality medical diagnostic imaging equipment across Tier 2, 3, and 4 towns in India
Yescarta is First CAR T-cell therapy to receive NCCN treatment guideline category 1 recommendation --
It is one of the 15 medical device manufacturers approved under the government’s PLI scheme
An estimated 21 million American women experience BV
Subscribe To Our Newsletter & Stay Updated
